Abstract:There is growing interest in the role that the bed nucleus of the stria terminalis (BNST) and central nucleus of the amygdala (CeA), components of the extended amygdala, play in drug addiction. Within the BNST and CeA, there is an extensive system of intrinsic, primarily GABAergic, interconnections known to synthesize a variety of neuropeptides, including corticotrophin-releasing factor (CRF). The actions of CRF at extrahypothalamic sites,including the BNST and CeA, have been implicated in stress responses and… Show more
“…One potential site is the bed nucleus of the stria terminalis (BNST). In this brain area, antagonism of either CRF receptors or b adrenoceptors attenuates footshock-stressinduced reinstatement of cocaine seeking (Erb and Stewart, 1999;Erb et al, 2001;Leri et al, 2002). In addition, 6-OHDA lesions of the main input to the BNST, the ventral noradrenergic bundle originating from the lateral tegmental noradrenergic nuclei (Aston-Jones et al, 1999), attenuate footshock-stress-induced reinstatement of heroin seeking (Shaham et al, 2000b); see also Wang et al (2001) for a similar finding using a morphine conditioned place preference model.…”
Section: Role Of Noradrenaline and Crf In Stress-induced Reinstatemenmentioning
The major problem in treating excessive eating is high rates of relapse to maladaptive eating habits during diet treatments; this relapse is often induced by stress or anxiety states. Preclinical studies have not explored this clinical problem. Here, we adapted a reinstatement model (commonly used to study relapse to abused drugs) to examine the role of stress and anxiety in relapse to palatable food seeking during dieting. Rats were placed on restricted diet (75-80% of daily standard food) and for 12 intermittent training days (9 h/day, every other day) lever-pressed for palatable food pellets (25% fat, 48% carbohydrate) under a fixed ratio 1 (20-s timeout) reinforcement schedule. Subsequently, the rats were given 10 daily extinction sessions during which lever presses were not reinforced, and were then injected with yohimbine (an a-2 adrenoceptor antagonist that induces stress and anxiety in humans and non-humans) or given a single food pellet to assess reinstatement of food seeking. The rats rapidly learned to lever press for the palatable pellets and across the training days the ratio of timeout nonreinforced lever presses to reinforced lever presses progressively increased more than three-fold, suggesting the development of compulsive eating behavior. After extinction, yohimbine injections and pellet priming reliably reinstated food seeking. The corticotropin-releasing factor 1 (CRF 1 ) receptor antagonist antalarmin attenuated the reinstatement induced by yohimbine, but not pellet priming. Antalarmin also reversed yohimbine's anxiogenic effects in the social interaction test. These data suggest that CRF is involved in stress-induced relapse to palatable food seeking, and that CRF 1 antagonists should be considered for the treatment of maladaptive eating habits.
“…One potential site is the bed nucleus of the stria terminalis (BNST). In this brain area, antagonism of either CRF receptors or b adrenoceptors attenuates footshock-stressinduced reinstatement of cocaine seeking (Erb and Stewart, 1999;Erb et al, 2001;Leri et al, 2002). In addition, 6-OHDA lesions of the main input to the BNST, the ventral noradrenergic bundle originating from the lateral tegmental noradrenergic nuclei (Aston-Jones et al, 1999), attenuate footshock-stress-induced reinstatement of heroin seeking (Shaham et al, 2000b); see also Wang et al (2001) for a similar finding using a morphine conditioned place preference model.…”
Section: Role Of Noradrenaline and Crf In Stress-induced Reinstatemenmentioning
The major problem in treating excessive eating is high rates of relapse to maladaptive eating habits during diet treatments; this relapse is often induced by stress or anxiety states. Preclinical studies have not explored this clinical problem. Here, we adapted a reinstatement model (commonly used to study relapse to abused drugs) to examine the role of stress and anxiety in relapse to palatable food seeking during dieting. Rats were placed on restricted diet (75-80% of daily standard food) and for 12 intermittent training days (9 h/day, every other day) lever-pressed for palatable food pellets (25% fat, 48% carbohydrate) under a fixed ratio 1 (20-s timeout) reinforcement schedule. Subsequently, the rats were given 10 daily extinction sessions during which lever presses were not reinforced, and were then injected with yohimbine (an a-2 adrenoceptor antagonist that induces stress and anxiety in humans and non-humans) or given a single food pellet to assess reinstatement of food seeking. The rats rapidly learned to lever press for the palatable pellets and across the training days the ratio of timeout nonreinforced lever presses to reinforced lever presses progressively increased more than three-fold, suggesting the development of compulsive eating behavior. After extinction, yohimbine injections and pellet priming reliably reinstated food seeking. The corticotropin-releasing factor 1 (CRF 1 ) receptor antagonist antalarmin attenuated the reinstatement induced by yohimbine, but not pellet priming. Antalarmin also reversed yohimbine's anxiogenic effects in the social interaction test. These data suggest that CRF is involved in stress-induced relapse to palatable food seeking, and that CRF 1 antagonists should be considered for the treatment of maladaptive eating habits.
“…For example, the BNST is involved in the anxiogenic effects of cocaine intoxication (Wenzel et al, 2014). In addition, there is compelling evidence that the BNST mediates stressinduced reinstatement of drug-seeking behavior (Buffalari and See, 2011;Erb et al, 2001;Flavin and Winder, 2013;Jennings et al, 2013a), thus serving an important role in understanding relapse following a period of abstinence. Similar to the light-enhanced startle and CRF-enhanced startle described earlier, withdrawal from drugs of abuse also enhances startle response, providing a model for testing effects of pharmacological agents on withdrawal.…”
Section: An Emerging Role For the Bnst In Addictionmentioning
confidence: 99%
“…However, there is some evidence that reinstatement of drug-seeking behavior is uniquely mediated by the BNST (Erb et al, 2001;Lu et al, 2003;Shaham et al, 2003), although many addiction studies find similarities in CeA and BNST response (eg, McFarland et al, 2004). These studies highlight the importance of the BNST for understanding mechanisms underlying addiction.…”
Section: An Emerging Role For the Bnst In Addictionmentioning
The consequences of chronic stress on brain structure and function are far reaching. Whereas stress can produce short-term adaptive changes in the brain, chronic stress leads to long-term maladaptive changes that increase vulnerability to psychiatric disorders, such as anxiety and addiction. These two disorders are the most prevalent psychiatric disorders in the United States, and are typically chronic, disabling, and highly comorbid. Emerging evidence implicates a tiny brain region-the bed nucleus of the stria terminalis (BNST)-in the body's stress response and in anxiety and addiction. Rodent studies provide compelling evidence that the BNST plays a central role in sustained threat monitoring, a form of adaptive anxiety, and in the withdrawal and relapse stages of addiction; however, little is known about the role of BNST in humans. Here, we review current evidence for BNST function in humans, including evidence for a role in the production of both adaptive and maladaptive anxiety. We also review preliminary evidence of the role of BNST in addiction in humans. Together, these studies provide a foundation of knowledge about the role of BNST in adaptive anxiety and stress-related disorders. Although the field is in its infancy, future investigations of human BNST function have tremendous potential to illuminate mechanisms underlying stressrelated disorders and identify novel neural targets for treatment.
“…The Function of the CRF Receptors in the BNST AL May be Pathway-Dependent Chronic stress and CRF dysregulation in the BNST have been linked to many traits commonly associated with the amygdala dysfunction including fear (Walker et al, 2003), anxiety (Ventura-Silva et al, 2012), anhedonia (Stout et al, 2000), addiction (Erb et al, 2001), and the emotional component of visceral and somatic pain (Deyama et al, 2007;Tran et al, 2012c). Our investigation focused primarily on anxiety and pain behaviors induced by a chronic repeated psychological stressor.…”
Section: The Effect Of Was On Crf Mechanisms In the Bnst Almentioning
Corticotropin-releasing factor (CRF)-mediated mechanisms in the bed nucleus of the stria terminalis (BNST) have a pivotal role in stressinduced anxiety and hyperalgesia. Although CRF is known to activate two receptor subtypes, CRF 1 and CRF 2 , attempts to delineate the specific role of each subtype in modulating anxiety and nociception have been inconsistent. Here we test the hypothesis that CRF 1 and CRF 2 receptor activation in the anteriolateral BNST (BNST AL ) facilitates divergent mechanisms modulating comorbid anxiety and hyperalgesia. Microinfusions of the specific antagonists CP376395 and Astressin 2 B into the BNST AL were used to investigate CRF 1 and CRF 2 receptor functions, respectively. We found that CRF 1 and CRF 2 receptors in the BNST AL had opposing effects on exploratory behavior in the elevated plus-maze, somatic mechanical threshold, and the autonomic and endocrine response to stress. However, CRF 1 or CRF 2 receptor antagonism in the BNST AL revealed complementary roles in facilitating the acoustic startle and visceromotor reflexes. Our results suggest that the net effect of CRF 1 and CRF 2 receptor activation in the BNST AL is pathway-dependent and provides important insight into the CRF receptor-associated circuitry that likely underpins stress-induced pathologies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.